Table 2.
Macular edemaa | Nepafenac n = 125 |
Vehicle n = 126 |
P-valueb |
---|---|---|---|
|
|
||
n (%) | n (%) | ||
Within 30 days | 3 (2.4) | 11 (8.7) | 0.029 |
Within 60 days | 3 (2.4) | 19 (15.1) | <0.001 |
Within 90 days | 4 (3.2) | 21 (16.7) | <0.001 |
Notes:
Macular edema was defined as ≥30% increase from the presurgical baseline in central subfield macular thickness as measured by optical coherence tomography (Stratus OCT 3);
P-value was calculated from a chi-square test.